215 related articles for article (PubMed ID: 17139682)
1. Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: short-term regulation by intrinsic and extrinsic pathways.
Moranta D; Esteban S; García-Sevilla JA
J Neurosci Res; 2007 Feb; 85(3):656-67. PubMed ID: 17139682
[TBL] [Abstract][Full Text] [Related]
2. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: an in vivo electrochemical study.
Wu WC; Wang Y; Chai CY
Chin J Physiol; 2008 Jun; 51(3):152-9. PubMed ID: 18935910
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.
Alvaro-Bartolomé M; Esteban S; García-Gutiérrez MS; Manzanares J; Valverde O; García-Sevilla JA
Br J Pharmacol; 2010 Jun; 160(3):643-56. PubMed ID: 20590568
[TBL] [Abstract][Full Text] [Related]
6. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
Niederhoffer N; Szabo B
J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
[TBL] [Abstract][Full Text] [Related]
8. A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells.
Davis MI; Ronesi J; Lovinger DM
J Biol Chem; 2003 Dec; 278(49):48973-80. PubMed ID: 14517212
[TBL] [Abstract][Full Text] [Related]
9. Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects.
Pan B; Zhong P; Sun D; Liu QS
J Neurosci; 2011 Aug; 31(31):11244-55. PubMed ID: 21813685
[TBL] [Abstract][Full Text] [Related]
10. Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats.
Pfitzer T; Niederhoffer N; Szabo B
Br J Pharmacol; 2004 Jul; 142(6):943-52. PubMed ID: 15226190
[TBL] [Abstract][Full Text] [Related]
11. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
[TBL] [Abstract][Full Text] [Related]
12. Lithium attenuates cannabinoid-induced dependence in the animal model: involvement of phosphorylated ERK1/2 and GSK-3β signaling pathways.
Rahimi HR; Dehpour AR; Mehr SE; Sharifzadeh M; Ghahremani MH; Razmi A; Ostad SN
Acta Med Iran; 2014; 52(9):656-63. PubMed ID: 25325202
[TBL] [Abstract][Full Text] [Related]
13. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
[TBL] [Abstract][Full Text] [Related]
14. Effects of Gαi
Ramos-Miguel A; Sánchez-Blázquez P; García-Sevilla JA
Pharmacol Rep; 2021 Aug; 73(4):1122-1135. PubMed ID: 33641090
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata.
Wallmichrath I; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.
Auclair N; Otani S; Soubrie P; Crepel F
J Neurophysiol; 2000 Jun; 83(6):3287-93. PubMed ID: 10848548
[TBL] [Abstract][Full Text] [Related]
17. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
Brzózka MM; Fischer A; Falkai P; Havemann-Reinecke U
Behav Brain Res; 2011 Apr; 218(2):280-7. PubMed ID: 21070814
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
Ramos-Miguel A; García-Sevilla JA
Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex.
Oropeza VC; Page ME; Van Bockstaele EJ
Brain Res; 2005 Jun; 1046(1-2):45-54. PubMed ID: 15927549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
